RENB -
Lunai Bioworks Inc. Common Stock
Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
--- |
--- |
--- |
--- |
--- |
--- |
--- |
--- |
Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
Earnings & Ratios
- Basic EPS:
- 0.0
- Diluted EPS:
- 0.0
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- VWAP:
- 1.2
- RVol:
Events
Period |
Kind |
Movement |
Occurred At |
Related News
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
Aug 20, 2025 01:44
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
Jul 29, 2025 19:01
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025 19:12
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025 15:05
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
Apr 01, 2025 11:00
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
Feb 26, 2025 18:25
Investors Eye Biotech Sector as Cancer Therapy Market Surges
Feb 19, 2025 15:06
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Jan 06, 2025 14:15
Predictive Oncology Announces Agreement to be Acquired by Renovaro
Jan 06, 2025 14:10
Renovaro Regains Compliance with NASDAQ Listing Requirement
Dec 20, 2024 20:40